Climb Bio (CLYM) Other Non-Current Assets (2020 - 2026)

Climb Bio has reported Other Non-Current Assets for 7 years, with the latest figure at $1.5 million in Q1 2026.

• For the quarter ending Q1 2026, Other Non-Current Assets rose 1242.11% year-over-year to $1.5 million; the trailing twelve-month figure through Mar 2026 stood at $1.5 million (up 1242.11% YoY), and the FY2025 full-year result was $1.5 million, up 9462.5% from the prior year.
• Other Non-Current Assets for Q1 2026 stood at $1.5 million, roughly flat from $1.5 million in the prior quarter.
• The five-year high for Other Non-Current Assets was $1.5 million in Q3 2025, with the low at $15000.0 in Q3 2023.
• Historically, Other Non-Current Assets has averaged $671187.5 across 5 years, with a median of $610500.0 in 2022.
• Annual changes were most pronounced in 2023 — Other Non-Current Assets plunged 97.3% — and 2025, when it surged 9462.5%.
• Climb Bio's Other Non-Current Assets stood at $128000.0 in 2022, then tumbled by 88.28% to $15000.0 in 2023, then advanced by 6.67% to $16000.0 in 2024, then surged by 9462.5% to $1.5 million in 2025, then changed by 0.0% to $1.5 million in 2026.
• The last three Other Non-Current Assets figures came in at $1.5 million (Q1 2026), $1.5 million (Q4 2025), and $1.5 million (Q3 2025), per Business Quant data.